Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.

Research output: Contribution to journal › Article › peer-review

Cite this

@article{5a87156bc9c341c0b7fdb648fffd6b21,

title = "Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.",

author = "Victor Gault and JC Parker and P Harriott and MH Mooney and Peter Flatt and Finbarr O'Harte",

year = "2003",

language = "English",

volume = "20 (S2",

pages = "36--36",

journal = "Diabetic medicine",

issn = "1464-5491",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Major metabolite of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), acts as a GIP receptor antagonist in vivo.

AU - Gault, Victor

AU - Parker, JC

AU - Harriott, P

AU - Mooney, MH

AU - Flatt, Peter

AU - O'Harte, Finbarr

PY - 2003

Y1 - 2003

M3 - Article

SN - 1464-5491

VL - 20 (S2

SP - 36

EP - 36

JO - Diabetic medicine

JF - Diabetic medicine

ER -